Related Experiment Video

Updated: Aug 15, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Hepatitis C: current approaches in pediatrics

Carolina Rumbo1

  • 1Pediatric Liver/Liver Transplant Program, Division of Pediatric Hepatology and Recanati/Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY 10029, USA. carolina.rumbo@msnyuhealth.org

Pediatric Transplantation
|September 24, 2005
PubMed

Insights

Chronic hepatitis C virus (HCV) infection is a major cause of liver disease in adults. This overview focuses on the distinct aspects of chronic HCV in children, including acquisition, progression, and treatment.

Area of Science:

  • Hepatology
  • Pediatric Infectious Diseases
  • Virology

Background:

  • Chronic hepatitis C virus (HCV) infection is a significant global health concern, primarily affecting adults.
  • HCV is a leading cause of liver disease and the most common indication for liver transplantation in the USA.
  • Hepatitis C in children is less common, with limited data on its clinical presentation and management.

Purpose of the Study:

  • To provide a comprehensive overview of chronic hepatitis C in pediatric populations.
  • To highlight the differences in HCV infection between children and adults.
  • To summarize current knowledge on the epidemiology, clinical course, and treatment of pediatric HCV.

Main Methods:

  • Literature review of studies on chronic hepatitis C in children.
  • Analysis of epidemiological data and clinical case reports.
  • Synthesis of information regarding viral acquisition, disease progression, and therapeutic options in pediatric patients.

Main Results:

  • Hepatitis C infection in children differs from adults in terms of acquisition routes and natural history.
  • Pediatric HCV may present unique challenges in diagnosis and management.
  • Specific treatment strategies and outcomes in children require further investigation.

Conclusions:

  • Chronic hepatitis C in children represents a distinct clinical entity compared to adults.
  • Further research is needed to fully understand the long-term implications and optimize treatment for pediatric HCV.
  • Raising awareness and improving diagnostic and therapeutic approaches for childhood hepatitis C are crucial.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...